Is Sorrento Therapeutics for real?

Is Sorrento Therapeutics for real?

Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19.

Similarly, Is Sorrento a good company?

Is Sorrento Therapeutics a good company to work for? Sorrento Therapeutics has an overall rating of 3.5 out of 5, based on over 71 reviews left anonymously by employees. 73% of employees would recommend working at Sorrento Therapeutics to a friend and 58% have a positive outlook for the business.

Where is Sorrento Pharmaceuticals located? Company Description: Sorrento Therapeutics, Inc. is located in San Diego, CA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry.

Thereof, What does Sorrento Therapeutics do?

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases.

Who owns Sorrento Therapeutics Inc?

Top 10 Owners of Sorrento Therapeutics Inc

Stockholder Stake Shares owned
BlackRock Fund Advisors 5.29% 18,198,029
The Vanguard Group, Inc. 4.33% 14,901,597
SSgA Funds Management, Inc. 4.25% 14,595,754
Geode Capital Management LLC 1.54% 5,301,256

Is Sorrento Therapeutics a Chinese company?

(NASDAQ: SRNE; « Sorrento »), announced today that its subsidiary, Levena Biopharma Co., Ltd. (« Levena »), has completed construction and put into operation a 25,000 square foot Good Manufacturing Practice (GMP) manufacturing facility in Suzhou, China.

What does the company Sorrento do?

(Sorrento) is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex.

How many employees does Sorrento Therapeutics have?

Sorrento Therapeutics, Inc. has 799 total employees across all of its locations and generates $52.90 million in sales (USD).

Just $139.99 *

Year Revenue
2018 21.19
2019 31.43
2020 39.99

Will Sorrento get FDA approval?

(Nasdaq: SRNE, « Sorrento ») today announced that it has received clearance from the FDA for its investigational new drug application (IND) for intranasal (IN) STI-9199 (COVISHIELD) to study the safety and pharmacokinetics in healthy volunteers.

Is Dr Henry Ji Korean?

Henry H. Ji is an American entrepreneur and businessperson.

Is Sorrento a Chinese company?

The company manufactures antibody drug conjugates and has a major Chinese manufacturing facility.

What is Abivertinib?

Abivertinib maleate is a third-generation EGFR tyrosine kinase inhibitor and BTK Inhibitor. The starting dose is 200 mg p.o. QD for up to 28 days.

What is Fintel io?

Fintel.io is a leading equity research platform designed to help quant-driven investors make better investing decisions. Fintel provides deep analytics on a variety of market data, including fund ownership, insider trading activity, short interest, and company financials.

Who owns Sorrento pharmaceuticals?

Ownership Sorrento Therapeutics Inc.

The Vanguard Group, Inc.

Who is Sorrento Therapeutics owned by?

ZTlido® and G-MAB™ are trademarks owned by Scilex Pharmaceuticals Inc. and Sorrento, respectively.

When was Sorrento Therapeutics founded?

Sorrento Therapeutics Inc (NASDAQ:SRNE)

It operates through the Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

What does it mean when a stock is squeezed?

The term squeeze can be used to describe several situations that involve some sort of market pressure. In finance, the term is used to describe situations wherein short-sellers purchase stock to cover losses or when investors sell long positions to take capital gains off the table.

Does Fintel have an app?

For a limited time, you can sign up for a Forever Free Fintel account. This membership level allows you access to some great features, including a custom dashboard that updates automatically.

Sign Up for a Forever Free Fintel Account.

Short Interest shares – source: NASDAQ
Short Interest Ratio 2.56 Days to Cover

How often is Fintel updated?

Update Frequency: Intraday every 30 minutes.

Who is invested in Sorrento?

Top 10 Owners of Sorrento Therapeutics Inc

Stockholder Stake Total value ($)
BlackRock Fund Advisors 5.94% 46,041,013
The Vanguard Group, Inc. 4.86% 37,701,040
SSgA Funds Management, Inc. 4.76% 36,927,258
Geode Capital Management LLC 1.73% 13,412,178

Who founded Sorrento Therapeutics?

Sorrento Therapeutics raises a $2,300,000 venture round. Sorrento Therapeutics was founded by Henry Ji.

Join TheMoney.co community and don’t forget to share this post !

Quitter la version mobile